CIRM Adds Info on Possible Endorsement of Public Insurance Option
The California stem cell agency has posted a host of wide-ranging links to documents dealing with the public health insurance option that it will consider endorsing at its Legislative Subcommittee meeting next Thursday.
They range from Wall Street Journal and New York Times articles to pieces in support and against the plan, which is being considered by …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.